EdgeMarketInstruments › ACRV

ACRV — Acrivon Therapeutics, Inc.

US Healthcare Pharma & biotech equity mkt cap 94.3M
2.21 +0.45% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.29 · high 3.01

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-11-15.

Performance

1 day+0.45%
1 week+13.33%
1 month+32.34%
3 months+23.46%
6 months+44.44%
Year to date-10.16%
1 year+70.00%
3 years-80.37%

Technicals

RSI 1480.4
vs 50-day avg+26.43%
vs 200-day avg+19.08%
Volatility 1y95.0%
Max drawdown 1y-57.14%
Avg volume 30d431.9K
Daily bars held944
History from2022-11-15

Measured signals that fired on ACRV

datesignal measured base rate
2026-03-02Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-18Blume-Jensen Peter
President and CEO
Open-market sale1.2K2.012.5K
2026-08-18Masson Kristina
EVP - Business Operations
Open-market sale1.2K2.012.5K
2026-08-18Devroe Eric
Chief Operating Officer
Open-market sale6042.011.2K
2026-08-18Blume-Jensen Peter
President and CEO
Open-market sale4842.01973
2026-08-18Masson Kristina
EVP - Business Operations
Open-market sale4842.01973
2026-08-18Gamelin Erick
Chief Development Officer
Open-market sale4002.01804
2026-08-18Miller Mary
Chief Legal Officer
Open-market sale1852.01372
2026-08-18Peterson Katharine
Chief Accounting Officer
Open-market sale1012.01203
2026-08-04Levy Adam D.
Chief Financial Officer
Open-market sale1.1K1.571.8K
2026-07-21Miller Mary
Chief Legal Officer
Open-market sale5731.761.0K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
RA CAPITAL MANAGEMENT, L.P.11.6M8.3M
Sands Capital Alternatives, LLC3.0M2.1M
WELLINGTON MANAGEMENT GROUP LLP1.2M888.1K
RENAISSANCE TECHNOLOGIES LLC1.1M758.4K
VANGUARD CAPITAL MANAGEMENT LLC1.0M722.0K
MARSHALL WACE, LLP779.0K560.4K
TWO SIGMA INVESTMENTS, LP541.3K389.4K
JANE STREET GROUP, LLC333.2K239.7K
GEODE CAPITAL MANAGEMENT, LLC328.7K236.4K
BlackRock, Inc.290.4K208.9K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
42026-08-202026-08-18on EDGAR ↗
42026-08-202026-08-18on EDGAR ↗
42026-08-202026-08-18on EDGAR ↗
42026-08-202026-08-18on EDGAR ↗
42026-08-202026-08-18on EDGAR ↗
SCHEDULE 13G/A2026-08-13on EDGAR ↗
S-82026-08-12on EDGAR ↗
8-K2026-08-122026-08-12on EDGAR ↗

Short selling

Avg short volume, 90d48.0% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about ACRV

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open ACRV in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →